MIRA Pharmaceuticals, Inc.
General ticker "MIRA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $20.5M (TTM average)
MIRA Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 2.7%: low 0.75$, high 0.80$
Factors to consider:
- Total employees count: 3 as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operational and conduct risks, Inability to raise capital, Clinical trial failure, Regulatory and compliance, Product candidate development
- Current price 25.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.96$, 2.16$]
- 2026-12-31 to 2027-12-31 estimated range: [0.95$, 2.15$]
Financial Metrics affecting the MIRA estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.87 <= 0.30
- Positive: 5.54 < Industry operating cash flow per share per price (median), % of 6.49
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Shareholder equity ratio, % of 93.67 > 63.79
- Positive: Industry earnings per price (median), % of 6.62 > 4.29
- Negative: negative Net income
Short-term MIRA quotes
Long-term MIRA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.17MM | $0.00MM |
| Operating Expenses | $8.53MM | $8.02MM | $10.49MM |
| Operating Income | $-8.53MM | $-7.85MM | $-10.49MM |
| Non-Operating Income | $-3.46MM | $0.00MM | $0.05MM |
| Interest Expense | $3.46MM | $0.00MM | $0.00MM |
| R&D Expense | $1.57MM | $3.31MM | $1.72MM |
| Income(Loss) | $-11.98MM | $-7.85MM | $-10.44MM |
| Net Income(Loss)* | $-11.98MM | $-7.85MM | $-10.44MM |
| Stockholders Equity | $4.37MM | $2.20MM | $10.39MM |
| Assets | $4.93MM | $2.92MM | $11.09MM |
| Operating Cash Flow | $-4.53MM | $-5.56MM | $-4.66MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $8.78MM | $3.79MM | $8.18MM |
| Earnings Per Share** | $-0.65 | $-0.51 | $-0.44 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.